Updates are available Correction dated 2022-12-26
Click to view Correction: https://doi.org/10.1007/s10484-022-09577-9
-
Authors
Roley-Roberts, Michelle E. https://orcid.org/0000-0002-9269-418X
Pan, Xueliang https://orcid.org/0000-0002-2342-3212
Bergman, Rachel
Tan, Yubo https://orcid.org/0000-0002-7495-5446
Hendrix, Kyle
deBeus, Roger https://orcid.org/0000-0001-9426-2690
Kerson, Cynthia https://orcid.org/0000-0001-5861-1443
Arns, Martijn https://orcid.org/0000-0002-0610-7613
Ging Jehli, Nadja R. https://orcid.org/0000-0002-1071-0693
Connor, Shea
Schrader, Constance
Arnold, L. Eugene https://orcid.org/0000-0002-0886-0692
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02251743 at ClinicalTrials.govDocuments that mention this clinical trial
For Which Children with ADHD is TBR Neurofeedback Effective? Comorbidity as a Moderator
https://doi.org/10.1007/s10484-022-09575-x
A diffusion decision model analysis of the cognitive effects of neurofeedback for ADHD.
https://doi.org/10.1037/neu0000932
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (R01-MH100144)
National Institute of Mental Health (R01-MH100144)
National Institute of Mental Health (R01-MH100144)
National Institute of Mental Health (R01-MH100144)
National Institute of Mental Health (R01-MH100144)
National Institute of Mental Health (R01-MH100144)
National Institute of Mental Health (R01-MH100144)
National Institute of Mental Health (R01-MH100144)
National Institute of Mental Health (R01-MH100144)
National Center for Advancing Translational Sciences (8UL18TR000090-05)
National Center for Advancing Translational Sciences (8UL18TR000090-05)
National Center for Advancing Translational Sciences (8UL18TR000090-05)
National Center for Advancing Translational Sciences (8UL18TR000090-05)
Ohio State University
- License Information
-
More Information
Article History
Accepted: 8 December 2022
First Online: 16 December 2022
Change Date: 26 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10484-022-09577-9
Declarations
:
: Dr. Arnold has received research funding from Curemark, Forest, Lilly, Neuropharm, Novartis, Noven, Shire, Supernus, Roche, and YoungLiving (as well as NIH and Autism Speaks), has consulted with Gowlings, Neuropharm, Organon, Pfizer, Sigma Tau, Shire, Tris Pharma, and Waypoint, and been on advisory boards for Arbor, Ironshore, Novartis, Noven, Otsuka, Pfizer, Roche, Seaside Therapeutics, Sigma Tau, Shire. Dr. Arns is (unpaid) director and owner of Research Institute Brainclinics, a minority shareholder in neuroCare Group (Munich, Germany), and a co-inventor on 4 patent applications related to EEG, neuromodulation and psychophysiology, but receives no royalties related to these patents; Research Institute Brainclinics received research funding from Brain Resource (Sydney, Australia), UrgoTech and neuroCare Group (Munich, Germany), and equipment support from Deymed, neuroConn and Magventure. Dr. Barterian receives royalties from Springer Nature. Dr. deBeus has received research funding from the Commonwealth Health Research Board of Virginia, VuBay Foundation, Riverside Healthcare Foundation, Edwin Joseph Foundation, and NIMH; he is on the Board of Directors for the International Society for Neurofeedback and Research and has a clinic NC where he performs neurofeedback among other clinical services. Dr. Kerson is Founder, CEO, and Director of Applied Psychophysiology Education (APEd). Dr. Roley-Roberts has received research funding from American Psychological Foundation, Foundation for Education and Research in Biofeedback and Related Sciences, Foundation for Neurofeedback and Neuromodulation Research, NIMH, and NIH. Drs. Pan and Schrader, Ms. Bergman, Ms. Connor, and Mr. Tan have no disclosures.
: This study was approved by The Ohio State University and University of North Carolina at Ashville Institutional Review Boards prior to beginning recruitment.
: All research participants provided informed consent to participate in the study, and consented to allowing the research team to publish using the data collected as part of their participation in the research study.
